Ann Surg Oncol (2018) 25:2261–2270 https://doi.org/10.1245/s10434-018-6540-4 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y RNA-Seq of Circulating Tumor Cells in Stage II–III Breast Cancer 1 2 1 1 Julie E. Lang, MD , Alexander Ring, MD, PhD , Tania Porras, MS , Pushpinder Kaur, PhD , Victoria A. Forte, 3 1 4 5 6 MD , Neal Mineyev, MD , Debu Tripathy, MD , Michael F. Press, MD, PhD , and Daniel Campo, PhD Section of Surgical Oncology, Department of Surgery and University of Southern California Norris Cancer Center, University of Southern California, Los Angeles, CA; Department of Oncology, University Hospital Zurich, Zurich, Switzerland; Division of Medical Oncology, Department of Medicine, Maimonides Medical Center, New York, NY; 4 5 Department of Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, TX; Department of Pathology and University of Southern California Norris Cancer Center, University of Southern California, Los Angeles, CA; Department of Biological Sciences, University of Southern California, Los Angeles, CA ABSTRACT CTC RNA-seq subtype assessed by the PAM50 classiﬁ- Background. We characterized the whole transcriptome cation genes was highly discordant, both with the subtype of circulating tumor cells (CTCs) in
Annals of Surgical Oncology – Springer Journals
Published: Jun 4, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud